CIMADAMORE, Alessia
CIMADAMORE, Alessia
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
2022-01-01 Krajewski, W; Aumatell, J; Subiela, Jd; Nowak, Ł; Tukiendorf, A; Moschini, M; Basile, G; Poletajew, S; Małkiewicz, B; Del Giudice, F; Maggi, M; Chung, Bi; Cimadamore, A; Galosi, Ab; Fave, Rfd; D'Andrea, D; Shariat, Sf; Hornak, J; Babjuk, M; Chorbińska, J; Teoh, Jy; Muilwijk, T; Joniau, S; Tafuri, A; Antonelli, A; Panunzio, A; Alvarez-Maestro, M; Simone, G; Mastroianni, R; Łaszkiewicz, J; Lonati, C; Zamboni, S; Simeone, C; Niedziela, Ł; Candela, L; Macek, P; Contieri, R; Hidalgo, Bg; Rivas, Jg; Sosnowski, R; Mori, K; Mir, C; Soria, F; González-Padilla, Da; Faba, Òr; Palou, J; Ploussard, G; Rajwa, P; Hałoń, A; Laukhtina, E; Pradere, B; Tully, K; Burgos, Fj; Cidre, Máj; Szydełko, T
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets
2017-01-01 Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review
2021-01-01 Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Mazzucchelli, R.; Luciano, R.; Scarpelli, M.; Montorsi, F.; Montironi, R.
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies
2018-01-01 Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R.
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF?
2021-01-01 Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F.
Agent-Based Learning Model for the Obesity Paradox in RCC
2021-01-01 Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E.
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer
2020-01-01 Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Mariani, C.; Battelli, N.; Montironi, R.; Massari, F.
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt
2021-01-01 Mollica, V.; Marchetti, A.; Rosellini, M.; Nuvola, G.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Montironi, R.; Massari, F.
An update on immunotherapy in uro-oncology
2021-01-01 Cimadamore, A.; Rizzo, A.; Mollica, V.; Massari, F.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Santoni, M.; Montironi, R.
An update on investigational therapies that target STAT3 for the treatment of cancer
2021-01-01 Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N.
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
2020-01-01 Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo
Are liver nested stromal epithelial tumors always low aggressive?
2017-01-01 Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R.
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
2018-01-01 Di Nunno, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Fiorentino, M.; Ciccarese, C.; Iacovelli, R.; Cheng, L.; Lopez-Beltran, A.; Massari, F.; Montironi, R.
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer
2018-01-01 Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R.
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial
2021-01-01 Denize, Thomas; Farah, Subrina; Cimadamore, Alessia; Flaifel, Abdallah; Walton, Emily; A Sticco-Ivins, Maura; Labaki, Chris; A Braun, David; Sun, Maxine; Wang, Evelyn; Xie, Wanling; K Choueiri, Toni; Signoretti, Sabina
Biomarkers of angiogenesis and clinical outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Randomized Phase III METEOR Trial
2022-03-24 Cimadamore, Alessia
Biphasic Tumors of the Urogenital Tract: Selected Topics
2019-01-01 Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
2021-01-01 Santoni, Matteo; Massari, Francesco; Bracarda, Sergio; Procopio, Giuseppe; Milella, Michele; De Giorgi, Ugo; Basso, Umberto; Aurilio, Gaetano; Incorvaia, Lorena; Martignetti, Angelo; Rizzo, Mimma; Cartenì, Giacomo; Grande, Enrique; Matrana, Marc R.; Crabb, Simon; Vau, Nuno; Sorgentoni, Giulia; Cimadamore, Alessia; Montironi, Rodolfo; Battelli, Nicola
Bone targeting agents in patients with metastatic prostate cancer: State of the art
2021-01-01 Mollica, V.; Rizzo, A.; Rosellini, M.; Marchetti, A.; Ricci, A. D.; Cimadamore, A.; Scarpelli, M.; Bonucci, C.; Andrini, E.; Errani, C.; Santoni, M.; Montironi, R.; Massari, F.
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
2021-01-01 Murrone, A.; Cantini, L.; Pecci, F.; Cognigni, V.; Copparoni, C.; Rinaldi, S.; Fiordoliva, I.; Monaco, F.; Rubini, C.; Barbisan, F.; Cimadamore, A.; Bianchi, F.; Tomasetti, M.; Amati, M.; Santarelli, L.; Berardi, R.; Giampieri, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer | 1-gen-2022 | Krajewski, W; Aumatell, J; Subiela, Jd; Nowak, Ł; Tukiendorf, A; Moschini, M; Basile, G; Poletajew, S; Małkiewicz, B; Del Giudice, F; Maggi, M; Chung, Bi; Cimadamore, A; Galosi, Ab; Fave, Rfd; D'Andrea, D; Shariat, Sf; Hornak, J; Babjuk, M; Chorbińska, J; Teoh, Jy; Muilwijk, T; Joniau, S; Tafuri, A; Antonelli, A; Panunzio, A; Alvarez-Maestro, M; Simone, G; Mastroianni, R; Łaszkiewicz, J; Lonati, C; Zamboni, S; Simeone, C; Niedziela, Ł; Candela, L; Macek, P; Contieri, R; Hidalgo, Bg; Rivas, Jg; Sosnowski, R; Mori, K; Mir, C; Soria, F; González-Padilla, Da; Faba, Òr; Palou, J; Ploussard, G; Rajwa, P; Hałoń, A; Laukhtina, E; Pradere, B; Tully, K; Burgos, Fj; Cidre, Máj; Szydełko, T | |
| Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets | 1-gen-2017 | Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez beltran, Antonio; Montironi, Rodolfo | |
| Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review | 1-gen-2021 | Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Mazzucchelli, R.; Luciano, R.; Scarpelli, M.; Montorsi, F.; Montironi, R. | |
| Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies | 1-gen-2018 | Massari, F.; Santoni, M.; di Nunno, V.; Cheng, L.; Lopez-Beltran, A.; Cimadamore, A.; Gasparrini, S.; Scarpelli, M.; Battelli, N.; Montironi, R. | |
| Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? | 1-gen-2021 | Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F. | |
| Agent-Based Learning Model for the Obesity Paradox in RCC | 1-gen-2021 | Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E. | |
| An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer | 1-gen-2020 | Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Mariani, C.; Battelli, N.; Montironi, R.; Massari, F. | |
| An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt | 1-gen-2021 | Mollica, V.; Marchetti, A.; Rosellini, M.; Nuvola, G.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Montironi, R.; Massari, F. | |
| An update on immunotherapy in uro-oncology | 1-gen-2021 | Cimadamore, A.; Rizzo, A.; Mollica, V.; Massari, F.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Santoni, M.; Montironi, R. | |
| An update on investigational therapies that target STAT3 for the treatment of cancer | 1-gen-2021 | Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N. | |
| Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications | 1-gen-2020 | Aurilio, Gaetano; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Verri, Elena; Scarpelli, Marina; Massari, Francesco; Cheng, Liang; Santoni, Matteo; Montironi, Rodolfo | |
| Are liver nested stromal epithelial tumors always low aggressive? | 1-gen-2017 | Meletani, T; Cantini, L; Lanese, A; Nicolini, D; Cimadamore, A; Agostini, A; Ricci, Giulia; Antognoli, S; Mandolesi, A; Cortelazzo, GUIDO MARIA; Alaggio, R; Giuseppetti, Gm; Scarpelli, M; Vivarelli, M; Berardi, R. | |
| Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer | 1-gen-2018 | Di Nunno, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Fiorentino, M.; Ciccarese, C.; Iacovelli, R.; Cheng, L.; Lopez-Beltran, A.; Massari, F.; Montironi, R. | |
| Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer | 1-gen-2018 | Cimadamore, A.; Gasparrini, S.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Giunchi, F.; Fiorentino, M.; Scarpelli, M.; Montironi, R. | |
| Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial | 1-gen-2021 | Denize, Thomas; Farah, Subrina; Cimadamore, Alessia; Flaifel, Abdallah; Walton, Emily; A Sticco-Ivins, Maura; Labaki, Chris; A Braun, David; Sun, Maxine; Wang, Evelyn; Xie, Wanling; K Choueiri, Toni; Signoretti, Sabina | |
| Biomarkers of angiogenesis and clinical outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Randomized Phase III METEOR Trial | 24-mar-2022 | Cimadamore, Alessia | |
| Biphasic Tumors of the Urogenital Tract: Selected Topics | 1-gen-2019 | Montironi, R; Mazzucchelli, R; Gasparrini, S; Cimadamore, A; Galosi, Ab; Raspollini, Mr; Lopez-Beltran, A; Cheng, L; Scarpelli, M | |
| Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? | 1-gen-2021 | Santoni, Matteo; Massari, Francesco; Bracarda, Sergio; Procopio, Giuseppe; Milella, Michele; De Giorgi, Ugo; Basso, Umberto; Aurilio, Gaetano; Incorvaia, Lorena; Martignetti, Angelo; Rizzo, Mimma; Cartenì, Giacomo; Grande, Enrique; Matrana, Marc R.; Crabb, Simon; Vau, Nuno; Sorgentoni, Giulia; Cimadamore, Alessia; Montironi, Rodolfo; Battelli, Nicola | |
| Bone targeting agents in patients with metastatic prostate cancer: State of the art | 1-gen-2021 | Mollica, V.; Rizzo, A.; Rosellini, M.; Marchetti, A.; Ricci, A. D.; Cimadamore, A.; Scarpelli, M.; Bonucci, C.; Andrini, E.; Errani, C.; Santoni, M.; Montironi, R.; Massari, F. | |
| BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma | 1-gen-2021 | Murrone, A.; Cantini, L.; Pecci, F.; Cognigni, V.; Copparoni, C.; Rinaldi, S.; Fiordoliva, I.; Monaco, F.; Rubini, C.; Barbisan, F.; Cimadamore, A.; Bianchi, F.; Tomasetti, M.; Amati, M.; Santarelli, L.; Berardi, R.; Giampieri, R. |